Tokyo, Sept. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059003) titled 'Evaluation of the Effect of the Test Beverage on GLP-1 Secretion' on Sept. 5.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - CPCC Company Limited
Condition:
Condition - Male/female adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the effect of a single intake of the test beverage on circulating GLP-1 secretion, and its effects on blood glucose, insulin, and subjective visual analogue scale (VAS) ratings....